This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date : 12/20/2017 - 12/20/2017
Location : Silver Spring, MD
Subject : Opioids Epidemic
FDA Participant/Group : KRISTIN DAVIS; ANNA FINE; YOLANDA JENKINS; MAARIKA KIMBRELL; LAUREN SILVIS; ELIZABETH DICKINSON; ANNA ABRAM; KATHLEEN QUINN; THERESA TOIGO;
Non FDA Participant/Group : Justine Handelman; John Cierisanso; Kim Holland (Blue Cross Blue Shield Association (BCBSA);

Official Name : Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner

No Significant Event

Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name : Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs

No Significant Event

Official Name : RADM Denise Hinton , Acting Chief Scientist

No Significant Event

Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date : 12/18/2017 - 12/18/2017
Location : Silver Spring, MD
Subject : Medical Imaging and Technology Alliance: Third Party Servicing
FDA Participant/Group : WILLIAM MAISEL; VALERIE FLOURNOY; JOSEPH SHAWKY; LAUREL BURK; DARYLL DYKES; KATELYN BITTLEMAN;
Non FDA Participant/Group : James Nestel; Wayne Moore; Diane Wurzburger; Bob Bove; Cassie Scherer; Donna Haire; Peter Weems (Medical Imaging and Technology Alliance);

Event Date : 12/21/2017 - 12/21/2017
Location : Silver Spring, MD
Subject : Next Generation Sequencing (NGS)
FDA Participant/Group : STAYCE BECK; JOSHUA ST. PIERRE; DONNA ROSCOE; LAURA KOONTZ; REENA PHILIP; EUNICE LEE; ELIZABETH HILLEBRENNER;
Non FDA Participant/Group : Amy Cunniffe (SplitOak Strategies LLC); David Spetzler; Russ Farr; (Caris Life Sciences);

Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name : Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name : Rebecca K. Wood, J.D., Chief Counsel

Event Date : 12/19/2017 - 12/19/2017
Location : Silver Spring, Maryland
Subject : Importance of New Medication Assisted Treatments(MATS) for Public Health–Legal Issues
FDA Participant/Group : JENNIFER SCHWARTZ; GIOIA GUERRIERI; ELIZABETH DICKINSON; DOUGLAS THROCKMORTON; COLLEEN KELLY; NISHA SHAH; GRAIL SIPES; CELIA WINCHELL; PETER STEIN; NANCY BOOCKER; SHARON HERTZ; KAREN SCHIFTER;
Non FDA Participant/Group : Scott Lassman (Goodwin Procter LLP); David McIntyre , Genie Bailey , Joshua Sherman, Mike Derkacz , Paul Varki , Sonnie Kim (Braeburn Pharmaceuticals Incorporated); Lisa Dwyer, Sheldon Bradshaw (King & Spalding LLP);